Lexaria Bioscience Corp.
LEXX · NASDAQ
5/31/2025 | 2/28/2025 | 11/30/2024 | 8/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4,592 | $6,469 | $8,078 | $6,500 |
| Short-Term Investments | $34 | $74 | $40 | $56 |
| Receivables | $358 | $331 | $263 | $154 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $823 | $850 | $444 | $1,188 |
| Total Curr. Assets | $5,807 | $7,724 | $8,826 | $7,898 |
| Property Plant & Equip (Net) | $354 | $358 | $399 | $390 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $516 | $506 | $505 | $517 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $64 | $64 | $64 | $64 |
| Total NC Assets | $935 | $929 | $968 | $970 |
| Other Assets | $0 | $25 | $0 | $0 |
| Total Assets | $6,741 | $8,678 | $9,794 | $8,868 |
| Liabilities | – | – | – | – |
| Payables | $1,447 | $1,279 | $262 | $1,058 |
| Short-Term Debt | $30 | $29 | $58 | $56 |
| Tax Payable | $11 | $0 | $7 | $9 |
| Deferred Revenue | $0 | $0 | $0 | $5 |
| Other Curr. Liab. | $0 | $514 | -$29 | -$28 |
| Total Curr. Liab. | $1,488 | $1,822 | $298 | $1,099 |
| LT Debt | $87 | $94 | $102 | $109 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $87 | $94 | $102 | $109 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $117 | $124 | $131 | $137 |
| Total Liabilities | $1,575 | $1,917 | $400 | $1,209 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $20 | $18 | $17 | $16 |
| Retained Earnings | -$60,765 | -$56,976 | -$54,262 | -$51,559 |
| AOCI | -$81 | -$118 | -$23 | -$20 |
| Other Equity | $66,378 | $64,221 | $64,042 | $59,599 |
| Total Equity | $5,552 | $7,145 | $9,774 | $8,036 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$386 | -$384 | -$380 | -$377 |
| Total Liab. & Tot. Equity | $6,741 | $8,678 | $9,794 | $8,868 |
| Net Debt | -$4,475 | -$6,345 | -$7,919 | -$6,334 |